Bioluminate Inc

Bioluminate Inc. (BioLuminate) is a medical device company engaged in the development, marketing and commercialization of a diagnostic device for early breast cancer diagnosis. BioLuminate is partnership with Morrison & Foerster LLP to expand the coverage offered by the NASA patent and prepare additional patents conceived by the BioLuminate team. Presently, Bioluminate is developing a new platform technology which provides significant information in real time and other future applications of this technology could include prostate, lung, colon, cervical and brain cancers. The company product will improve breast cancer screening effectiveness, especially in younger women, where mammograms are less effective because of denser breast tissue. BioLuminate is headquartered at California, the US.

Street: 
3371 Melendy Drive
City: 
San Carlos
Postcode: 
94070
Federal State : 
United States
WebSite: 
www.bioluminate.com
Fax: 
--

Company Index Score

Current Index Score Historical Index Score
  • Bioluminate Inc currently scores 50 % in the index.
  • Bioluminate Inc is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Bioluminate Inc is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets